ABOUT US
A global leader in innovative genomic
technology and diagnostic tests.
What’s new at Agendia?
Get the latest updates on our company and products, as well as new developments in genomic science.
News
In the News
News
Media Releases
Agendia Brings Together Thought Leaders in Molecular Diagnostics and Medical Oncology
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, August 29, 2012 – Agendia, an innovative molecular cancer diagnostics company and leader in personalized medicine, conducted one of its premiere thought leadership events, “Present and Future Trends in Read More
Agendia Earns ISO Certification for Facilities in Amsterdam and Irvine
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, August 20, 2012 – Agendia, an innovative molecular cancer diagnostics company and leader in personalized medicine, today announced that it has been granted the International Organization for Standardization (ISO) Read More
Agendia Appoints Dr. Stefan Glück to Chair Medical Advisory Board
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, August 9, 2012 – Agendia, an innovative molecular cancer diagnostics company and leader in personalized medicine, today announced that Stefan Glück, MD, PhD, will lead the company’s Medical Advisory Read More
Agendia Welcomes Dr. Mark Gittleman to Expanding Medical Advisory Board
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, July 10, 2012 – Agendia, an innovative molecular cancer diagnostics company and leader in personalized medicine, today announced that Dr. Mark Gittleman, Medical Director of Breast Care Specialists and Read More